Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy. | J Transl Med | 2024 | 38246995 | PubTator, text mining | PubMed |
| Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation. | Sci Adv | 2024 | 38241367 | PubTator, text mining | PubMed |
| Kinase inhibitor pulldown assay (KiP) for clinical proteomics. | Clin Proteomics | 2024 | 38225548 | PubTator, text mining | PubMed |
| Mechanism of lysine oxidase-like 1 promoting synovial inflammation mediating rheumatoid arthritis development. | Aging (Albany NY) | 2024 | 38217541 | PubTator, text mining | PubMed |
| Non-coding RNAs as potential therapeutic targets for receptor tyrosine kinase signaling in solid tumors: current status and future directions. | Cancer Cell Int | 2024 | 38200584 | PubTator, text mining | PubMed |
| Single nucleus transcriptome of a "Super RV" shows increased insulin and angiogenesis signaling. | bioRxiv | 2024 | 38196630 | PubTator, text mining | PubMed |
| SNRPB promotes the progression of hepatocellular carcinoma via regulating cell cycle, oxidative stress, and ferroptosis. | Aging (Albany NY) | 2024 | 38189879 | PubTator, text mining | PubMed |
| Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres. | J Transl Med | 2024 | 38184610 | PubTator, text mining | PubMed |
| Screening of coexpression genes of immune cells in breast cancer tissues. | Medicine (Baltimore) | 2024 | 38181289 | PubTator, text mining | PubMed |
| METTL3/YTHDF1 m6A axis promotes tumorigenesis by enhancing DDR2 expression in ovarian cancer. | Pathol Res Pract | 2024 | 38154356 | PubTator, text mining | PubMed |
| Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis. | J Cell Mol Med | 2024 | 38140764 | PubTator, text mining | PubMed |
| Circular RNAs in intracranial aneurysms: Emerging roles in pathogenesis, diagnosis and therapeutic intervention. | Noncoding RNA Res | 2024 | 38125753 | PubTator, text mining | PubMed |
| Novel insights into the role of Discoidin domain receptor 2 (DDR2) in cancer progression: a new avenue of therapeutic intervention. | Matrix Biol | 2024 | 38081526 | PubTator, text mining | PubMed |
| The Interaction between Collagen 1 and High Mannose Type CD133 Up-Regulates Glutamine Transporter SLC1A5 to Promote the Tumorigenesis of Glioblastoma Stem Cells. | Adv Sci (Weinh) | 2024 | 37997289 | PubTator, text mining | PubMed |
| DDR2-regulated arginase activity in ovarian cancer-associated fibroblasts promotes collagen production and tumor progression. | Oncogene | 2024 | 37996700 | PubTator, text mining | PubMed |
| Advances in cardiac tissue engineering and heart-on-a-chip. | J Biomed Mater Res A | 2024 | 37909362 | PubTator, text mining | PubMed |
| Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis. | Cancer Res Treat | 2024 | 37752792 | PubTator, text mining | PubMed |
| A Phase II Trial of Nintedanib in Patients with Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma: In-Depth Analysis of Nintedanib Arm from the KCSG HN 15-16 TRIUMPH Trial. | Cancer Res Treat | 2024 | 37475136 | PubTator, text mining | PubMed |
| High-accuracy prediction of colorectal cancer chemotherapy efficacy using machine learning applied to gene expression data. | Front Physiol | 2023 | 38304289 | PubTator, text mining | PubMed |
| Limitations and potential of immunotherapy in ovarian cancer. | Front Immunol | 2023 | 38264664 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=8